PT92807B - Processo para a preparacao de uma vacina de proteina de membrana externa meningococia classe 1 - Google Patents

Processo para a preparacao de uma vacina de proteina de membrana externa meningococia classe 1 Download PDF

Info

Publication number: PT92807B
Authority: PT; Portugal
Prior art keywords: class; protein; outer membrane; meningococcal; membrane protein
Prior art date: 1989-01-06

Application number

PT9280790A

Other languages

English (en)

Portuguese (pt)

Other versions

PT92807A (pt

Inventor

Robert C Seid Jr

Peter R Paradiso

Jan T Poolman

Peter Hoogerhout

Emmanuel J H J Wiertz

Peter Van Der Ley

John Edward Heckels

Ian Nicholas Clarke

Original Assignee

Nederlanden Staat

Praxis Biolog Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-06

Filing date

1990-01-08

Publication date

1995-12-29

1989-01-06 Priority claimed from NL8900036A external-priority patent/NL8900036A/nl

1990-01-08 Application filed by Nederlanden Staat, Praxis Biolog Inc filed Critical Nederlanden Staat

1990-07-31 Publication of PT92807A publication Critical patent/PT92807A/pt

1995-12-29 Publication of PT92807B publication Critical patent/PT92807B/pt

Links

238000000034 method Methods 0.000 title claims abstract description 101
238000002360 preparation method Methods 0.000 title claims abstract description 33
230000008569 process Effects 0.000 title claims abstract description 30
108010052285 Membrane Proteins Proteins 0.000 title claims description 23
229940023143 protein vaccine Drugs 0.000 title description 3
101710116435 Outer membrane protein Proteins 0.000 claims abstract description 146
108090000623 proteins and genes Proteins 0.000 claims abstract description 120
102000004169 proteins and genes Human genes 0.000 claims abstract description 85
239000012634 fragment Substances 0.000 claims abstract description 83
229960005486 vaccine Drugs 0.000 claims abstract description 76
108010038807 Oligopeptides Proteins 0.000 claims abstract description 55
102000015636 Oligopeptides Human genes 0.000 claims abstract description 55
241000588650 Neisseria meningitidis Species 0.000 claims abstract description 54
239000000203 mixture Substances 0.000 claims abstract description 34
239000012528 membrane Substances 0.000 claims abstract description 20
239000002671 adjuvant Substances 0.000 claims abstract description 14
201000010099 disease Diseases 0.000 claims abstract description 8
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 8
241000040340 Oat mosaic virus Species 0.000 claims abstract 2
238000009472 formulation Methods 0.000 claims abstract 2
235000018102 proteins Nutrition 0.000 claims description 83
108090000765 processed proteins & peptides Proteins 0.000 claims description 77
108010040721 Flagellin Proteins 0.000 claims description 48
150000001413 amino acids Chemical class 0.000 claims description 43
210000001744 T-lymphocyte Anatomy 0.000 claims description 32
235000001014 amino acid Nutrition 0.000 claims description 26
230000001580 bacterial effect Effects 0.000 claims description 25
241000700605 Viruses Species 0.000 claims description 19
230000000844 anti-bacterial effect Effects 0.000 claims description 19
229920001282 polysaccharide Polymers 0.000 claims description 19
150000004676 glycans Chemical class 0.000 claims description 18
239000005017 polysaccharide Substances 0.000 claims description 18
238000003780 insertion Methods 0.000 claims description 16
230000037431 insertion Effects 0.000 claims description 16
239000003981 vehicle Substances 0.000 claims description 16
230000021615 conjugation Effects 0.000 claims description 14
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims description 14
230000002068 genetic effect Effects 0.000 claims description 14
244000005700 microbiome Species 0.000 claims description 14
108091034117 Oligonucleotide Proteins 0.000 claims description 13
230000001681 protective effect Effects 0.000 claims description 13
230000028993 immune response Effects 0.000 claims description 12
241000894006 Bacteria Species 0.000 claims description 10
102000014914 Carrier Proteins Human genes 0.000 claims description 10
108010078791 Carrier Proteins Proteins 0.000 claims description 10
ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims description 9
230000004927 fusion Effects 0.000 claims description 9
-1 octyl glycoside Chemical class 0.000 claims description 9
108010013381 Porins Proteins 0.000 claims description 8
210000003719 b-lymphocyte Anatomy 0.000 claims description 8
102000007739 porin activity proteins Human genes 0.000 claims description 8
102000018697 Membrane Proteins Human genes 0.000 claims description 7
108020001507 fusion proteins Proteins 0.000 claims description 7
102000037865 fusion proteins Human genes 0.000 claims description 7
229920001542 oligosaccharide Polymers 0.000 claims description 7
150000002482 oligosaccharides Chemical class 0.000 claims description 7
108700018753 Neisseria porin Proteins 0.000 claims description 6
241000607142 Salmonella Species 0.000 claims description 6
239000003599 detergent Substances 0.000 claims description 6
150000007523 nucleic acids Chemical group 0.000 claims description 6
239000000126 substance Substances 0.000 claims description 6
238000003786 synthesis reaction Methods 0.000 claims description 6
208000015181 infectious disease Diseases 0.000 claims description 5
231100000699 Bacterial toxin Toxicity 0.000 claims description 4
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
239000004472 Lysine Substances 0.000 claims description 4
108020004511 Recombinant DNA Proteins 0.000 claims description 4
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 4
230000000890 antigenic effect Effects 0.000 claims description 4
239000000688 bacterial toxin Substances 0.000 claims description 4
235000018417 cysteine Nutrition 0.000 claims description 4
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
230000002797 proteolythic effect Effects 0.000 claims description 4
241000701161 unidentified adenovirus Species 0.000 claims description 4
102000004190 Enzymes Human genes 0.000 claims description 3
108090000790 Enzymes Proteins 0.000 claims description 3
239000003795 chemical substances by application Substances 0.000 claims description 3
IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 claims description 3
239000002502 liposome Substances 0.000 claims description 3
239000003053 toxin Substances 0.000 claims description 3
231100000765 toxin Toxicity 0.000 claims description 3
108700012359 toxins Proteins 0.000 claims description 3
241000701022 Cytomegalovirus Species 0.000 claims description 2
229920001213 Polysorbate 20 Polymers 0.000 claims description 2
239000001506 calcium phosphate Substances 0.000 claims description 2
229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
235000011010 calcium phosphates Nutrition 0.000 claims description 2
229960003964 deoxycholic acid Drugs 0.000 claims description 2
230000003308 immunostimulating effect Effects 0.000 claims description 2
230000002458 infectious effect Effects 0.000 claims description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 claims description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
125000003275 alpha amino acid group Chemical group 0.000 claims 10
101100263837 Bovine ephemeral fever virus (strain BB7721) beta gene Proteins 0.000 claims 1
101100316840 Enterobacteria phage P4 Beta gene Proteins 0.000 claims 1
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
108091007491 NSP3 Papain-like protease domains Proteins 0.000 claims 1
239000004365 Protease Substances 0.000 claims 1
239000003463 adsorbent Substances 0.000 claims 1
229940001981 carac Drugs 0.000 claims 1
238000003776 cleavage reaction Methods 0.000 claims 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
229930182470 glycoside Natural products 0.000 claims 1
150000002632 lipids Chemical class 0.000 claims 1
238000002515 oligonucleotide synthesis Methods 0.000 claims 1
230000017854 proteolysis Effects 0.000 claims 1
230000007017 scission Effects 0.000 claims 1
239000004094 surface-active agent Substances 0.000 claims 1
230000003053 immunization Effects 0.000 abstract description 3
238000002649 immunization Methods 0.000 abstract description 3
102000004196 processed proteins & peptides Human genes 0.000 description 42
108020004414 DNA Proteins 0.000 description 37
239000000562 conjugate Substances 0.000 description 35
210000004027 cell Anatomy 0.000 description 28
239000000427 antigen Substances 0.000 description 27
108091007433 antigens Proteins 0.000 description 27
102000036639 antigens Human genes 0.000 description 27
239000013598 vector Substances 0.000 description 27
238000011969 continuous reassessment method Methods 0.000 description 26
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 24
229940024606 amino acid Drugs 0.000 description 24
101150044687 crm gene Proteins 0.000 description 22
238000006243 chemical reaction Methods 0.000 description 21
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
239000000463 material Substances 0.000 description 19
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 18
238000010276 construction Methods 0.000 description 12
238000000746 purification Methods 0.000 description 12
230000004044 response Effects 0.000 description 12
238000013518 transcription Methods 0.000 description 12
238000001262 western blot Methods 0.000 description 12
241000588724 Escherichia coli Species 0.000 description 11
239000013612 plasmid Substances 0.000 description 11
230000035897 transcription Effects 0.000 description 11
230000002163 immunogen Effects 0.000 description 10
239000000047 product Substances 0.000 description 10
239000011780 sodium chloride Substances 0.000 description 10
239000000243 solution Substances 0.000 description 10
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
238000007792 addition Methods 0.000 description 9
238000004458 analytical method Methods 0.000 description 9
239000004202 carbamide Substances 0.000 description 9
210000003495 flagella Anatomy 0.000 description 9
239000000499 gel Substances 0.000 description 9
230000005847 immunogenicity Effects 0.000 description 9
239000006228 supernatant Substances 0.000 description 9
229960000814 tetanus toxoid Drugs 0.000 description 9
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
230000005875 antibody response Effects 0.000 description 8
239000002158 endotoxin Substances 0.000 description 8
239000013604 expression vector Substances 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 7
238000005119 centrifugation Methods 0.000 description 7
238000010367 cloning Methods 0.000 description 7
230000000694 effects Effects 0.000 description 7
238000002523 gelfiltration Methods 0.000 description 7
229920006008 lipopolysaccharide Polymers 0.000 description 7
241000699670 Mus sp. Species 0.000 description 6
108091028043 Nucleic acid sequence Proteins 0.000 description 6
239000001963 growth medium Substances 0.000 description 6
238000004128 high performance liquid chromatography Methods 0.000 description 6
230000001900 immune effect Effects 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
230000001717 pathogenic effect Effects 0.000 description 6
238000005215 recombination Methods 0.000 description 6
230000006798 recombination Effects 0.000 description 6
238000012163 sequencing technique Methods 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
230000014616 translation Effects 0.000 description 6
101150096316 5 gene Proteins 0.000 description 5
238000012270 DNA recombination Methods 0.000 description 5
238000002965 ELISA Methods 0.000 description 5
108091006905 Human Serum Albumin Proteins 0.000 description 5
102000008100 Human Serum Albumin Human genes 0.000 description 5
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
239000000872 buffer Substances 0.000 description 5
230000029087 digestion Effects 0.000 description 5
238000010790 dilution Methods 0.000 description 5
239000012895 dilution Substances 0.000 description 5
230000012010 growth Effects 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
239000003999 initiator Substances 0.000 description 5
238000010647 peptide synthesis reaction Methods 0.000 description 5
238000003752 polymerase chain reaction Methods 0.000 description 5
230000009257 reactivity Effects 0.000 description 5
238000003756 stirring Methods 0.000 description 5
230000009466 transformation Effects 0.000 description 5
238000013519 translation Methods 0.000 description 5
101150084750 1 gene Proteins 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
101710167887 Major outer membrane protein P.IA Proteins 0.000 description 4
230000005867 T cell response Effects 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
239000002253 acid Substances 0.000 description 4
238000003556 assay Methods 0.000 description 4
230000008859 change Effects 0.000 description 4
238000004587 chromatography analysis Methods 0.000 description 4
238000007796 conventional method Methods 0.000 description 4
239000012228 culture supernatant Substances 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
238000000502 dialysis Methods 0.000 description 4
239000003480 eluent Substances 0.000 description 4
230000006870 function Effects 0.000 description 4
210000004698 lymphocyte Anatomy 0.000 description 4
239000002609 medium Substances 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 4
SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
239000011734 sodium Substances 0.000 description 4
239000012064 sodium phosphate buffer Substances 0.000 description 4
230000000638 stimulation Effects 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
238000002255 vaccination Methods 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 description 3
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
238000001712 DNA sequencing Methods 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
241000233866 Fungi Species 0.000 description 3
108010051815 Glutamyl endopeptidase Proteins 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
241000588652 Neisseria gonorrhoeae Species 0.000 description 3
206010043376 Tetanus Diseases 0.000 description 3
241000700618 Vaccinia virus Species 0.000 description 3
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
229910052921 ammonium sulfate Inorganic materials 0.000 description 3
235000011130 ammonium sulphate Nutrition 0.000 description 3
239000012062 aqueous buffer Substances 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
210000004899 c-terminal region Anatomy 0.000 description 3
239000001110 calcium chloride Substances 0.000 description 3
229910001628 calcium chloride Inorganic materials 0.000 description 3
150000001720 carbohydrates Chemical group 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
239000012141 concentrate Substances 0.000 description 3
239000003431 cross linking reagent Substances 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
238000001514 detection method Methods 0.000 description 3
238000010828 elution Methods 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
238000013467 fragmentation Methods 0.000 description 3
238000006062 fragmentation reaction Methods 0.000 description 3
229960002989 glutamic acid Drugs 0.000 description 3
244000000058 gram-negative pathogen Species 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
229940031348 multivalent vaccine Drugs 0.000 description 3
108020004707 nucleic acids Proteins 0.000 description 3
102000039446 nucleic acids Human genes 0.000 description 3
230000003647 oxidation Effects 0.000 description 3
238000007254 oxidation reaction Methods 0.000 description 3
244000045947 parasite Species 0.000 description 3
244000052769 pathogen Species 0.000 description 3
229910052698 phosphorus Inorganic materials 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
229920001184 polypeptide Polymers 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
238000003860 storage Methods 0.000 description 3
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 3
229940033663 thimerosal Drugs 0.000 description 3
229940104230 thymidine Drugs 0.000 description 3
229940125575 vaccine candidate Drugs 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 2
FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 2
PYAFUXYGTYWWBP-UHFFFAOYSA-N 19-methoxynonadecane-1,2,3-triol Chemical compound COCCCCCCCCCCCCCCCCC(O)C(O)CO PYAFUXYGTYWWBP-UHFFFAOYSA-N 0.000 description 2
MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
108010053187 Diphtheria Toxin Proteins 0.000 description 2
102000016607 Diphtheria Toxin Human genes 0.000 description 2
244000182691 Echinochloa frumentacea Species 0.000 description 2
235000008247 Echinochloa frumentacea Nutrition 0.000 description 2
230000005526 G1 to G0 transition Effects 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
241000282412 Homo Species 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
108010002350 Interleukin-2 Proteins 0.000 description 2
108010074338 Lymphokines Proteins 0.000 description 2
102000008072 Lymphokines Human genes 0.000 description 2
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 2
201000009906 Meningitis Diseases 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
102100029251 Phagocytosis-stimulating peptide Human genes 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
241000125945 Protoparvovirus Species 0.000 description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
229940122605 Short-acting muscarinic antagonist Drugs 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
229920002125 Sokalan® Polymers 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
108010084754 Tuftsin Proteins 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000009471 action Effects 0.000 description 2
239000013543 active substance Substances 0.000 description 2
239000001166 ammonium sulphate Substances 0.000 description 2
230000002238 attenuated effect Effects 0.000 description 2
244000052616 bacterial pathogen Species 0.000 description 2
230000000721 bacterilogical effect Effects 0.000 description 2
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
230000001588 bifunctional effect Effects 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000000969 carrier Substances 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
238000004440 column chromatography Methods 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000011026 diafiltration Methods 0.000 description 2
239000005546 dideoxynucleotide Substances 0.000 description 2
PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 description 2
108700003601 dimethylglycine Proteins 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000000855 fermentation Methods 0.000 description 2
230000004151 fermentation Effects 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
208000002672 hepatitis B Diseases 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000036039 immunity Effects 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
238000005470 impregnation Methods 0.000 description 2
229940031551 inactivated vaccine Drugs 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
238000005342 ion exchange Methods 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
239000003550 marker Substances 0.000 description 2
208000037941 meningococcal disease Diseases 0.000 description 2
239000004005 microsphere Substances 0.000 description 2
239000011707 mineral Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
239000002773 nucleotide Substances 0.000 description 2
125000003729 nucleotide group Chemical group 0.000 description 2
238000012261 overproduction Methods 0.000 description 2
239000002245 particle Substances 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
229920001983 poloxamer Polymers 0.000 description 2
229920000768 polyamine Polymers 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
150000003077 polyols Chemical class 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
238000004007 reversed phase HPLC Methods 0.000 description 2
230000000405 serological effect Effects 0.000 description 2
229910001961 silver nitrate Inorganic materials 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
239000001488 sodium phosphate Substances 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000010532 solid phase synthesis reaction Methods 0.000 description 2
125000006850 spacer group Chemical group 0.000 description 2
238000010186 staining Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
IESDGNYHXIOKRW-LEOABGAYSA-N tuftsin Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-LEOABGAYSA-N 0.000 description 2
229940035670 tuftsin Drugs 0.000 description 2
241000701447 unidentified baculovirus Species 0.000 description 2
NKUZQMZWTZAPSN-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-bromoacetate Chemical compound BrCC(=O)ON1C(=O)CCC1=O NKUZQMZWTZAPSN-UHFFFAOYSA-N 0.000 description 1
BQWBEDSJTMWJAE-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-[(2-iodoacetyl)amino]benzoate Chemical compound C1=CC(NC(=O)CI)=CC=C1C(=O)ON1C(=O)CCC1=O BQWBEDSJTMWJAE-UHFFFAOYSA-N 0.000 description 1
AGJAUFUNZWHLKE-UHFFFAOYSA-N (2E,4E)-N-isobutyl-2,4-tetradecadienamide Natural products CCCCCCCCCC=CC=CC(=O)NCC(C)C AGJAUFUNZWHLKE-UHFFFAOYSA-N 0.000 description 1
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
IFKPLJWIEQBPGG-QGZVFWFLSA-N (5s)-6-(dimethylamino)-5-methyl-4,4-diphenylhexan-3-one Chemical compound C=1C=CC=CC=1C([C@H](C)CN(C)C)(C(=O)CC)C1=CC=CC=C1 IFKPLJWIEQBPGG-QGZVFWFLSA-N 0.000 description 1
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
101150028074 2 gene Proteins 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
WKALLSVICJPZTM-UHFFFAOYSA-N 3-[decyl(dimethyl)azaniumyl]propane-1-sulfonate Chemical compound CCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O WKALLSVICJPZTM-UHFFFAOYSA-N 0.000 description 1
101150111197 76 gene Proteins 0.000 description 1
108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
101100070525 Arabidopsis thaliana HEN1 gene Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
241001167018 Aroa Species 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
108020000946 Bacterial DNA Proteins 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
101100346198 Caenorhabditis elegans mpc-2 gene Proteins 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
241001478240 Coccus Species 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
108010060123 Conjugate Vaccines Proteins 0.000 description 1
241000412611 Consul Species 0.000 description 1
201000007336 Cryptococcosis Diseases 0.000 description 1
241000221204 Cryptococcus neoformans Species 0.000 description 1
229920002271 DEAE-Sepharose Polymers 0.000 description 1
238000007900 DNA-DNA hybridization Methods 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
101100491986 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) aromA gene Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
241000708493 Gelina Species 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
241000606768 Haemophilus influenzae Species 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
101150017040 I gene Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
239000004201 L-cysteine Substances 0.000 description 1
235000013878 L-cysteine Nutrition 0.000 description 1
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
239000004158 L-cystine Substances 0.000 description 1
235000019393 L-cystine Nutrition 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
108010054278 Lac Repressors Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
206010027202 Meningitis bacterial Diseases 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
241000588653 Neisseria Species 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
239000002033 PVDF binder Substances 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
201000005702 Pertussis Diseases 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
241000725643 Respiratory syncytial virus Species 0.000 description 1
241000702670 Rotavirus Species 0.000 description 1
108700031314 Rotavirus VP6 Proteins 0.000 description 1
241000607124 Salmonella enterica subsp. enterica serovar Muenchen Species 0.000 description 1
239000012506 Sephacryl® Substances 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
BHATUINFZWUDIX-UHFFFAOYSA-N Zwittergent 3-14 Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O BHATUINFZWUDIX-UHFFFAOYSA-N 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
PMZXXNPJQYDFJX-UHFFFAOYSA-N acetonitrile;2,2,2-trifluoroacetic acid Chemical compound CC#N.OC(=O)C(F)(F)F PMZXXNPJQYDFJX-UHFFFAOYSA-N 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
229940037003 alum Drugs 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000003321 amplification Effects 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
101150037081 aroA gene Proteins 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
238000007846 asymmetric PCR Methods 0.000 description 1
201000009904 bacterial meningitis Diseases 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
239000013602 bacteriophage vector Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
239000006161 blood agar Substances 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000000337 buffer salt Substances 0.000 description 1
244000309464 bull Species 0.000 description 1
210000004900 c-terminal fragment Anatomy 0.000 description 1
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 1
238000005277 cation exchange chromatography Methods 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
230000005859 cell recognition Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
229940031670 conjugate vaccine Drugs 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
101150054175 cro gene Proteins 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
229960003067 cystine Drugs 0.000 description 1
238000003381 deacetylation reaction Methods 0.000 description 1
238000010612 desalination reaction Methods 0.000 description 1
238000011033 desalting Methods 0.000 description 1
229960002086 dextran Drugs 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
229960003983 diphtheria toxoid Drugs 0.000 description 1
238000007599 discharging Methods 0.000 description 1
208000018459 dissociative disease Diseases 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000012847 fine chemical Substances 0.000 description 1
230000004992 fission Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
239000001307 helium Substances 0.000 description 1
229910052734 helium Inorganic materials 0.000 description 1
SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
238000000703 high-speed centrifugation Methods 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
210000005104 human peripheral blood lymphocyte Anatomy 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
125000001165 hydrophobic group Chemical group 0.000 description 1
238000002169 hydrotherapy Methods 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000010436 membrane biogenesis Effects 0.000 description 1
229960005037 meningococcal vaccines Drugs 0.000 description 1
IBIKHMZPHNKTHM-RDTXWAMCSA-N merck compound 25 Chemical compound C1C[C@@H](C(O)=O)[C@H](O)CN1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 IBIKHMZPHNKTHM-RDTXWAMCSA-N 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
244000000010 microbial pathogen Species 0.000 description 1
229940031346 monovalent vaccine Drugs 0.000 description 1
BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 1
125000001446 muramyl group Chemical group N[C@@H](C=O)[C@@H](O[C@@H](C(=O)*)C)[C@H](O)[C@H](O)CO 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
210000004898 n-terminal fragment Anatomy 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 1
101150073640 ompF gene Proteins 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
101150099358 pain gene Proteins 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
239000000863 peptide conjugate Substances 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229940031937 polysaccharide vaccine Drugs 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001012 protector Effects 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
101150079601 recA gene Proteins 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000003014 reinforcing effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
239000000523 sample Substances 0.000 description 1
239000012047 saturated solution Substances 0.000 description 1
238000011218 seed culture Methods 0.000 description 1
238000004513 sizing Methods 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000007974 sodium acetate buffer Substances 0.000 description 1
239000012475 sodium chloride buffer Substances 0.000 description 1
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
HHSGWIABCIVPJT-UHFFFAOYSA-M sodium;1-[4-[(2-iodoacetyl)amino]benzoyl]oxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)C1=CC=C(NC(=O)CI)C=C1 HHSGWIABCIVPJT-UHFFFAOYSA-M 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
108010037687 staphylococcin Proteins 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
229940031626 subunit vaccine Drugs 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
238000000825 ultraviolet detection Methods 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
239000012646 vaccine adjuvant Substances 0.000 description 1
229940124931 vaccine adjuvant Drugs 0.000 description 1
208000007089 vaccinia Diseases 0.000 description 1
239000004474 valine Substances 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
244000052613 viral pathogen Species 0.000 description 1
239000003643 water by type Substances 0.000 description 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

PT9280790A 1989-01-06 1990-01-08 Processo para a preparacao de uma vacina de proteina de membrana externa meningococia classe 1 PT92807B (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NL8900036A NL8900036A (nl)	1988-12-19	1989-01-06	Multivalent meningococcen klasse 1 buitenmembraaneiwit vaccin.
NL8901612A NL8901612A (nl)	1988-12-19	1989-06-26	Multivalent meningococcen klasse i buitenmembraaneiwit vaccin.

Publications (2)

Publication Number	Publication Date
PT92807A PT92807A (pt)	1990-07-31
PT92807B true PT92807B (pt)	1995-12-29

Family

ID=26646470

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT9280790A PT92807B (pt)	1989-01-06	1990-01-08	Processo para a preparacao de uma vacina de proteina de membrana externa meningococia classe 1

Country Status (2)

Country	Link
CA (1)	CA2007248C (fr)
PT (1)	PT92807B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN115851477B (zh) *	2022-05-12	2024-01-16	华南农业大学	一种大肠杆菌jc83及其应用
CN119264277A (zh) *	2024-09-19	2025-01-07	兰州大学	一种新型嵌合鞭毛蛋白及其应用
CN119371559A (zh) *	2024-09-30	2025-01-28	兰州大学	一种有效激活TLR5信号通路的大肠杆菌Nissle 1917鞭毛蛋白的嵌合蛋白及其应用

1990
- 1990-01-05 CA CA 2007248 patent/CA2007248C/fr not_active Expired - Lifetime
- 1990-01-08 PT PT9280790A patent/PT92807B/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT92807A (pt)	1990-07-31
CA2007248C (fr)	2007-07-10
CA2007248A1 (fr)	1990-07-06

Legal Events

Date

Code

Title

Description

1995-12-29

FG3A

Patent granted, date of granting

Effective date: 19950911

2010-09-21

MM4A

Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20100913

Publication	Publication Date	Title
EP0449958B1 (fr)	1995-03-22	Vaccin meningocoque de la proteine de la membrane externe de la classe 1
US7118757B1 (en)	2006-10-10	Meningococcal class 1 outer-membrane protein vaccine
Danve et al.	1993	Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals
Van Der Ley et al.	1995	Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine
JP4827196B2 (ja)	2011-11-30	髄膜炎菌類タンパク質ｎｍｂ１８７０のドメインおよびエピトープ
JP5566684B2 (ja)	2014-08-06	Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅに対する、組換え毒素Ａ／毒素Ｂワクチン
US20070148729A1 (en)	2007-06-28	Methods for increasing neisseria protein expression and compositions thereof
CA2040544C (fr)	2002-10-22	Vaccin de sous-unite actionobacillus pleuropneumoniae
Nurminen et al.	1992	The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity
PT728200E (pt)	2006-12-29	Genes de receptores de transferrina de haemophilus
WO2023067118A1 (fr)	2023-04-27	Vaccin multivalent d'acinetobacter baumannii déficient en lipopolysaccharides (lps)
Cope et al.	1990	Characterization of a mutant of Haemophilus influenzae type b lacking the P2 major outer membrane protein
AU744733B2 (en)	2002-02-28	Neisseria lactoferrin binding protein
Ward et al.	1996	Expression ofNeisseria meningitidisclass 1 porin as a fusion protein inEscherichia colli: the influence of liposomes and adjuvants on the production of a bactericidal immune reesponse
CA2007248C (fr)	2007-07-10	Vaccin antimeningococcique de classe 1 contenant une proteine de la membrane exterieure du meningocoque
EP1905831A2 (fr)	2008-04-02	Gènes récepteurs de lactoferrine de Moraxella
BRPI0709922A2 (pt)	2011-07-26	composiÇço farmacÊutica contendo a proteÍna nmb0606
BRPI0710064A2 (pt)	2011-08-02	composição farmacêutica contendo a proteìna nmb0938
JP2004529601A (ja)	2004-09-30	組換えインフルエンザ菌アドヘシンタンパク質
AU695173B2 (en)	1998-08-06	Novel opacity associated proteins, DNA encoding the same, and methods of use thereof
BRPI0620867A2 (pt)	2011-11-29	formulações farmacêuticas que contêm a proteìna nma0939
MXPA99011210A (es)	2000-06-01	Genes receptores de lactoferrina de moraxella